QualityStocksNewsBreaks Archives - Page 426 of 1387

FridayMar 18, 2022 12:58 pm

QualityStocksNewsBreaks – American Cannabis Partners’ Rare Approach Sets It Apart in Competitive Industry

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator contending for first place in the U.S. cannabis industry, relies on proven strategies such as mergers and acquisitions to strengthen its position in a competitive market. For ACP, due diligence is a top priority before acquiring any assets. Its website notes that its sights are set on listings in cannabis-friendly states, cannabis population demand, agricultural zoning, available licenses, and market value. ACP purchases land and equipment in full to keep it debt-free and liquid. After completing acquisitions, the company undertakes cost-effective measures to update and appraise properties to increase market…

FridayMar 18, 2022 12:42 pm

QualityStocksNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Confirms Potential of Optioned Gold Properties

StraightUp Resources (CSE: ST) (OTCQB: STUPF), a precious metals explorer, has spent the past year examining the potential for gold exploration on flagship properties it has optioned in Canada’s well-known greenstone belts in Ontario, anticipating persistent demand for the metal worldwide. “Ground magnetic surveys and helicopter-borne high-resolution aerial magnetic surveys have helped confirm the potential of StraightUp’s five gold properties in the Red Lake Mining region, such as ‘multiple areas of high merit and potential mineralization’ reported in November at the Ferdinand Gold Project, which consists of 17 contiguous mining claims covering 7,143 hectares (17,651 acres),” a recent article reads.…

FridayMar 18, 2022 11:39 am

QualityStocksNewsBreaks – Nowigence Inc.’s Pluaris(TM) Enabling Users to Learn More in Less Time

Nowigence has developed an off-the-shelf, cloud-based, artificial intelligence (“AI”) platform, called Pluaris(TM), that can successfully handle more than one task at a time. While a recent Forbes article declared multitasking might not be real, Nowigence’s Pluaris is. “Relying on artificial intelligence rather than human intelligence, Pluaris can do a myriad of things simultaneously. The game-changing app automatically monitors public news sources for identified topics of interest while also gathering information together and providing summaries, extracting intelligence and creating graphical analysis. It’s the ultimate multitasking platform,” a recent article reads. “And while Pluaris automates reading and analysis of textual data, the…

FridayMar 18, 2022 11:24 am

QualityStocksNewsBreaks – Red White & Bloom Brands Inc.’s (CSE: RWB) (OTCQX: RWBYF) Acquisition Strategy Spearheading Expansion, Premium Inventory Production

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a premium cannabis brand multistate operator, has been building assets steadily in Michigan, Florida, Illinois, Massachusetts, and Arizona, while working to establish the quality and consistency that wellness consumers seek. The company announced full licensing for manufacturing both medical and adult-use cannabis products in Michigan in January, along with the closing of a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in the city of Warren. A recent article reads: “The manufacturing facility is a key part of RWB’s acquisition strategy for 18 Michigan dispensaries, four cultivation facilities and…

ThursdayMar 17, 2022 3:05 pm

QualityStocksNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Playing Pivotal Role in Renaissance of Psychedelics

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, is among organizations, working alongside researchers at the center of the veritable renaissance of psychedelics. “Mydecine is playing a crucial role in advancing the knowledge of the benefits of psychedelics by developing innovative first- and second-generation novel compounds for the treatment of mental health and addiction and sequentially collaborating with academics to undertake vital clinical research on them. So far, Mydecine has partnered with Johns Hopkins University to launch a clinical trial utilizing psilocybin for smoking cessation. Led…

ThursdayMar 17, 2022 2:44 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Significant Milestone in Advancing Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, recently participated in the Virtual Investor 2022 Top Picks Conference. The company’s CEO John Climaco provided a corporate presentation and participated in a moderated questions and answer session during the event. Berubicin, a novel anthracycline and the first in its drug class to appear to cross the blood-brain barrier, is CNS Pharmaceuticals’ lead drug candidate. “The company is currently developing treatments using Berubicin for serious brain and central nervous system oncology indications, including glioblastoma…

ThursdayMar 17, 2022 2:08 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) to Host Virtual Town Hall

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced that it will be holding a virtual Town Hall at 11 a.m. PT / 2 p.m. ET on Thursday, March 31, 2022. The announcement reads, “Knightscope’s CEO, William Santana Li, will be taking 90 minutes of your questions in an ‘Ask Me Anything’ format. As long as he can legally answer it, he likely will! Click here to RSVP. The session will be livestreamed and recorded.” To view the full press release, visit https://ibn.fm/4HiFR About Knightscope Knightscope is an advanced security technology company…

ThursdayMar 17, 2022 1:29 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Issues Update on Key 2022 Goals and Milestones, Planned Uplist to National Exchange

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food and beverage industries, today updated stakeholders on the company's key 2022 goals. PBI believes these goals are attainable in the current fiscal year and that their achievement will put the company on a rapid path to sustained growth, value increase and profitability. “In addition to the record number of instrument orders for a month, interest and engagement with our enabling BaroFold Platform protein refolding services has grown significantly over…

ThursdayMar 17, 2022 1:00 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Subsidiary Names Seasoned Brand Veteran to Advisory Board

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company and its subsidiary, Applied Magix Inc., have announced a new member of the Applied Magix advisory Board. Michael Teitelbaum, a senior brand integrity manager at Jazwares, will be bringing his expertise to the board. In the announcement, Teitelbaum noted that he welcomes the opportunity to share his expertise and experience and guide Applied Magix to new heights. Applied Magix develops and resells Apple(R) ecosystem compatible products in the growing multibillion-dollar IoT smart-home and connected-car markets. “I’m genuinely excited to have Mike on our advisory board, offering us his expertise and experience,” said…

ThursdayMar 17, 2022 11:49 am

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO, Cofounder Featured on the Jesse Tee Show Interview

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, and company CEO and cofounder Matt Stang were spotlighted during a recent segment of the Jesse Tee Show. During the interview, Stang provided a summary of the journey to his present position with Delic Holdings, noting that he started as an intern with “High Times.” He worked in several positions at the publication, eventually buying out one of the owners. Stang also discussed the therapeutic potential of psychedelic compounds and provided a brief history of Delic. “In 2016, we put ‘High Times’ up…

Site Search

Company Search

Category: QualityStocksNewsBreaks